Testosterone cream for perimenopause: what the evidence actually says

What did @skincare.tiffany actually say?

Tiffany tried a testosterone pellet during perimenopause and says it caused her to gain 10 pounds, made her hair "fall out and dry and break," and didn't improve her symptoms, all within a month. Now she's switching to a topical testosterone cream, starting at one click and titrating up. She's asking her followers for dosing tips and tricks, specifically worried about hair loss returning.

To be clear: she's not making wild medical claims here. She's a patient sharing a lived experience, asking for community support. That's actually one of the more honest formats on HRT TikTok. But some of what she's implying about pellets versus cream deserves a closer look, and the crowd-sourced dosing advice she's seeking carries real risks that her video doesn't acknowledge.

Does the science back this up?

Her bad experience with the pellet is plausible, but the cream isn't automatically safer for hair. Both deliver testosterone, and androgenic alopecia risk depends on how much dihydrotestosterone (DHT) your body converts from that testosterone, not the delivery method itself.

Testosterone pellets are known for producing supraphysiologic peaks shortly after insertion, which could explain a sudden hair shedding episode. A 2014 review by Glaser and Dimitrakakis in Maturitas noted that pellets can produce higher and less predictable serum testosterone levels compared to topical formulations. That inconsistency is a legitimate clinical concern. Topical creams do tend to offer more gradual absorption and are easier to titrate, which is probably why her prescriber started her low. But a 2019 study by Islam et al. in JAMA Internal Medicine found significant variation in testosterone absorption even with standardized topical doses, meaning "starting slow" is smart but not a guarantee of stability. Her hair concerns are not paranoia; they are pharmacologically grounded. Whether the cream avoids the same outcome depends heavily on her individual androgen sensitivity and final therapeutic dose.

What did they get wrong (or right)?

She gets credit for one thing most TikTok HRT creators skip: she's actually working with a prescriber and following a titration protocol. "Starting with one click and working my way up" reflects a legitimate low-and-slow approach that aligns with current clinical guidance on female testosterone therapy.

Where things get shaky is the implicit framing that the pellet caused all those problems and the cream won't. Hair loss from testosterone in women is mediated primarily by DHT conversion, not the pellet format. If she had a genetic predisposition to androgenic alopecia, the cream could trigger the same response at similar testosterone levels. The pellet may have worsened things by overshooting her therapeutic range, which is a real issue with that delivery method, but the cream is not inherently protective for hair.

The 10-pound weight gain in one month is also worth questioning. Testosterone typically doesn't cause fat gain at therapeutic doses in women; if anything, studies like Shifren et al. (2000, NEJM) showed modest improvements in body composition. A rapid 10-pound gain in a month is more likely fluid retention, a concurrent dietary change, or a different hormonal shift entirely. Attributing it solely to the pellet is an understandable instinct but probably an oversimplification.

What should you actually know?

If you're a perimenopausal woman considering testosterone therapy, the delivery method matters less than getting your levels properly monitored. No TikTok commenter can give you useful dosing advice because your response depends on your baseline serum testosterone, SHBG levels, DHT conversion rate, and individual symptom profile. Crowd-sourced "click counts" are genuinely not a safe substitute for lab work.

For hair specifically, if you're worried about androgenic alopecia, ask your prescriber about monitoring DHT levels alongside total and free testosterone. Some clinicians also consider combining testosterone therapy with a topical DHT blocker like ketoconazole shampoo as a precautionary measure, though evidence for this in the context of female TRT is limited. The Endocrine Society's 2019 clinical practice guidelines still do not endorse routine testosterone therapy for women outside of specific indications like hypoactive sexual desire disorder, which means many women are navigating this without robust clinical infrastructure. That's worth knowing before you take your dosing cues from a comment section.